Trial intelligence / Profile preview

Simplifying rabies pre-exposure vaccination

2011-001612-62Phase 3Completed

Sponsor
Institute of Tropical Medicine Antwerp
Start
Aug 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3 trial of Human Diploid Cell Rabies Vaccine in rabies (2 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Primary: boostability of rabies antibodies on day 7 after booster vaccination. Started Aug 2011; status: completed.

02

Drugs

Human Diploid Cell Rabies Vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on 2011-001612-62.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001612-62.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call